干细胞衍生的胰腺内胚层细胞治疗 T1DM

Finding a way to safely replace the destroyed β-cells of patients with type 1 糖尿病 (T1DM) has long been a research goal in the T1DM field. 现在, two papers report preliminary findings from an ongoing phase I/II trial in which patients with T1DM received implants of stem-cell derived pancreatic endoderm cells within an encapsulation device named PEC-Direct.

分类: 干细胞疗法

NBScience

合同研究机构

干细胞疗法